Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

HLVX

HilleVax Inc

Dec 13 • 04:00PM ET

1.96

Dollar change -0.02
Percentage change -1.01	%

Healthcare • Biotechnology • USA • NASD

Peers: MRNA PFE JNJ AZN BNTX GSK NVAX DVAX VXRT ALT

| Held by: IWM VTI VXF IWN VTWO IWC IWO SBIO ITOT VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.09	Insider Own	55.64%	Shs Outstand	49.47M	Perf Week	-2.49%
Market Cap	96.63M	Forward P/E	-	EPS next Y	-1.92	Insider Trans	0.00%	Shs Float	22.09M	Perf Month	3.16%
Income	-150.28M	PEG	-	EPS next Q	-0.38	Inst Own	36.82%	Short Float	5.50%	Perf Quarter	9.50%
Sales	0.00M	P/S	-	EPS this Y	13.16%	Inst Trans	-11.96%	Short Ratio	6.48	Perf Half Y	-87.01%
Book/sh	3.73	P/B	0.53	EPS next Y	27.46%	ROA	-51.15%	Short Interest	1.21M	Perf Year	-86.69%
Cash/sh	3.84	P/C	0.51	EPS next 5Y	-	ROE	-62.24%	52W Range	1.55 - 20.22	Perf YTD	-87.79%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-241.80%	ROI	-73.06%	52W High	-90.31%	Beta	0.80
Dividend TTM	-	Quick Ratio	14.25	Sales past 5Y	0.00%	Gross Margin	-	52W Low	26.45%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	14.25	EPS Y/Y TTM	-9.50%	Oper. Margin	-	RSI (14)	53.41	Volatility	3.67% 3.72%
Employees	90	Debt/Eq	0.14	Sales Y/Y TTM	-	Profit Margin	-	Recom	3.00	Target Price	2.33
Option/Short	No / Yes	LT Debt/Eq	0.12	EPS Q/Q	35.83%	Payout	-	Rel Volume	1.28	Prev Close	1.98
Sales Surprise	-	EPS Surprise	-24.70%	Sales Q/Q	-	Earnings	Nov 07 BMO	Avg Volume	187.31K	Price	1.96
SMA20	2.42%	SMA50	4.42%	SMA200	-73.53%	Trades		Volume	239,132	Change	-1.01%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-09-24	Downgrade	Stifel	Buy → Hold	$34 → $3
Jul-09-24	Downgrade	Leerink Partners	Outperform → Market Perform	$28 → $2
Jul-09-24	Downgrade	H.C. Wainwright	Buy → Neutral	$28 → $2
Jul-08-24	Downgrade	JP Morgan	Overweight → Neutral	$24 → $5
Jul-08-24	Downgrade	Guggenheim	Buy → Neutral
Dec-13-23	Initiated	H.C. Wainwright	Buy	$28

Nov-07-24 08:00AM	HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress (GlobeNewswire)
Oct-14-24 12:00PM	What Makes HilleVax (HLVX) a New Buy Stock (Zacks)
Aug-08-24 07:20PM	HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress (GlobeNewswire)
Aug-01-24 11:53AM	HilleVax slashes workforce by 40% after norovirus vaccine trial failure (Pharmaceutical Technology)
Jul-31-24 04:00PM	HilleVax Announces Reduction in Force (GlobeNewswire)
09:35AM	Loading…
Jul-29-24 09:35AM	After Plunging -86.93% in 4 Weeks, Here's Why the Trend Might Reverse for HilleVax (HLVX) (Zacks)
Jul-11-24 09:35AM	Down -88.84% in 4 Weeks, Here's Why HilleVax (HLVX) Looks Ripe for a Turnaround (Zacks)
Jul-09-24 10:19AM	HilleVax (HLVX) Tanks as Norovirus Vaccine Study in Infants Fails (Zacks)
Jul-08-24 12:36PM	GRFS Stock Alert: Grifols Pops 20% on Takeover Interest (InvestorPlace) -88.34%
12:17PM	Why Is HilleVax (HLVX) Stock Down 87% Today? (InvestorPlace)
08:42AM	Takeda-spinout HilleVax sees stock sink 80% as norovirus vaccine flunks phase 2 trial in infants (FierceBiotech.com)
08:16AM	HilleVaxs norovirus vaccine ineffective in large trial of infants (BioPharma Dive)
07:30AM	HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants (GlobeNewswire)
May-23-24 02:15AM	Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX) (GuruFocus.com) -7.50%
May-10-24 02:26PM	HilleVax Inc (HLVX) Reports Increased Q1 Losses, Misses Analyst Earnings Expectations (GuruFocus.com)
11:55PM	Loading…
May-09-24 11:55PM	HLVX Stock Earnings: HilleVax Misses EPS for Q1 2024 (InvestorPlace)
04:05PM	HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress (GlobeNewswire)
Apr-14-24 12:52PM	10 Buy-Rated Stocks with Latest Insider Purchases (Insider Monkey)
Apr-06-24 01:33AM	Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX) (GuruFocus.com)
Mar-21-24 02:32AM	Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX) (GuruFocus.com)
Mar-20-24 09:53PM	HLVX Stock Earnings: HilleVax Beats EPS for Q4 2023 (InvestorPlace) -7.57%
04:00PM	HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress (GlobeNewswire)
Mar-08-24 11:55PM	Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX) (GuruFocus.com)
Feb-22-24 11:27PM	Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX) (GuruFocus.com) +5.12%
Feb-05-24 04:05PM	HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference (GlobeNewswire)
Jan-18-24 07:00AM	HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer (GlobeNewswire)
Jan-08-24 07:00AM	HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China (GlobeNewswire)
Jan-03-24 06:28PM	HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-19-23 01:01PM	Insider Sell Alert: Chief Medical Officer Astrid Borkowski Sells 10,000 Shares of HilleVax Inc ... (GuruFocus.com)
Dec-05-23 09:48PM	Insider Sell Alert: Chief Medical Officer Astrid Borkowski Sells 20,000 Shares of HilleVax Inc ... (GuruFocus.com)
09:55AM	Loading…
Nov-30-23 09:55AM	Wall Street Analysts Believe HilleVax, Inc. (HLVX) Could Rally 92.19%: Here's is How to Trade (Zacks)
Nov-21-23 11:03AM	Insider Sell Alert: Chief Medical Officer Astrid Borkowski Sells 10,000 Shares of HilleVax Inc ... (GuruFocus.com)
Nov-14-23 12:00PM	HilleVax, Inc. (HLVX) Moves to Buy: Rationale Behind the Upgrade (Zacks) +11.03%
09:55AM	Does HilleVax, Inc. (HLVX) Have the Potential to Rally 107.23% as Wall Street Analysts Expect? (Zacks)
Nov-09-23 04:05PM	HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress (GlobeNewswire) +6.18%
Nov-01-23 04:48PM	HilleVax to Present at Upcoming Investor Conferences (GlobeNewswire) +8.18%
Sep-26-23 04:01PM	HilleVax to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference (GlobeNewswire)
Sep-25-23 07:00AM	HilleVax Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares (GlobeNewswire)
Sep-19-23 08:05PM	HilleVax Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
04:09PM	HilleVax Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Aug-24-23 10:40AM	J.P. Morgan Sees up to 110% Gains in These 2 Stocks Heres Why They Could Soar (TipRanks)
Aug-14-23 05:08PM	Biotech behind 2022's largest local IPO delays norovirus vaccine (American City Business Journals) -7.26% -10.17%
07:00AM	HilleVax Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress (GlobeNewswire)
Jun-07-23 09:55AM	Wall Street Analysts Predict a 56.76% Upside in HilleVax, Inc. (HLVX): Here's What You Should Know (Zacks)
May-22-23 09:55AM	How Much Upside is Left in HilleVax, Inc. (HLVX)? Wall Street Analysts Think 87.76% (Zacks)
May-12-23 04:05PM	HilleVax Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress (GlobeNewswire)
May-09-23 07:00AM	HilleVax Announces Appointment of Nanette Cocero Ph.D., MBA, to its Board of Directors (GlobeNewswire)
Apr-25-23 06:45AM	HilleVax Announces Completion of Enrollment of NEST-IN1 Phase 2b Clinical Study of HIL-214 Norovirus Vaccine Candidate (GlobeNewswire)

HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kohli Aditya	Director	May 20 '24	Sale	15.45	6,000	92,689	776,878	May 22 05:40 PM
Kohli Aditya	Director	May 22 '24	Sale	14.73	6,000	88,372	764,878	May 22 05:40 PM
Kohli Aditya	Director	May 21 '24	Sale	14.21	6,000	85,230	770,878	May 22 05:40 PM
Kohli Aditya	Director	May 02 '24	Sale	14.01	6,000	84,081	783,601	May 03 07:12 PM
Kohli Aditya	Director	May 03 '24	Sale	14.15	723	10,233	782,878	May 03 07:12 PM
Kohli Aditya	Director	May 01 '24	Sale	14.03	175	2,456	789,601	May 03 07:12 PM
Frazier Life Sciences X, L.P.	10% Owner	Apr 04 '24	Buy	14.50	8,850	128,325	8,544,187	Apr 08 04:22 PM
Kohli Aditya	Director	Apr 03 '24	Sale	14.93	6,000	89,582	801,776	Apr 05 05:48 PM
Kohli Aditya	Director	Apr 04 '24	Sale	14.71	6,000	88,245	795,776	Apr 05 05:48 PM
Kohli Aditya	Director	Apr 05 '24	Sale	14.44	6,000	86,640	789,776	Apr 05 05:48 PM
McLoughlin Sean	Chief Operating Officer	Mar 28 '24	Buy	16.98	1,250	21,225	1,250	Apr 01 04:08 PM
Kohli Aditya	Director	Mar 18 '24	Sale	17.66	6,000	105,937	819,776	Mar 20 06:27 PM
Kohli Aditya	Director	Mar 19 '24	Sale	17.42	6,000	104,492	813,776	Mar 20 06:27 PM
Kohli Aditya	Director	Mar 20 '24	Sale	16.42	6,000	98,533	807,776	Mar 20 06:27 PM
Kohli Aditya	Director	Mar 06 '24	Sale	18.95	6,000	113,701	837,776	Mar 08 06:38 PM
Kohli Aditya	Director	Mar 08 '24	Sale	18.66	6,000	111,959	825,776	Mar 08 06:38 PM
Kohli Aditya	Director	Mar 07 '24	Sale	18.37	6,000	110,213	831,776	Mar 08 06:38 PM
Kohli Aditya	Director	Feb 22 '24	Sale	15.05	6,000	90,312	843,776	Feb 22 05:20 PM
Kohli Aditya	Director	Feb 21 '24	Sale	14.92	6,000	89,495	849,776	Feb 22 05:20 PM
Kohli Aditya	Director	Feb 20 '24	Sale	14.88	6,000	89,272	855,776	Feb 22 05:20 PM
Kohli Aditya	Director	Feb 12 '24	Sale	15.32	6,000	91,921	861,776	Feb 14 04:22 PM
Kohli Aditya	Director	Feb 08 '24	Sale	14.93	8,866	132,383	812,878	Feb 12 08:06 PM
Maltbie Shane	Chief Financial Officer	Feb 08 '24	Sale	14.93	3,576	53,395	40,656	Feb 12 07:51 PM
HERSHBERG ROBERT	See Remarks	Feb 08 '24	Sale	14.93	11,597	173,161	953,831	Feb 12 07:47 PM
Borkowski Astrid	Chief Medical Officer	Feb 08 '24	Sale	14.93	3,933	58,726	161,260	Feb 12 07:35 PM
Borkowski Astrid	Chief Medical Officer	Dec 15 '23	Sale	15.50	10,000	155,000	165,193	Dec 18 05:34 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HLVX

HilleVax Inc

Upgrade your FINVIZ experience